ASCO GU 2021: Retroperitoneal Lymph Node Dissection Should Be Considered First-Line for Metastatic Seminoma
Few short-term and no long-term complications were reported in the SEMS trial
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.